Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms

References

• Vanderlaan M, Zhu-Shimoni J, Lin S, Gunawan F, Waerner T, Van Cott KE. Experience with host cell protein impurities in biopharmaceuticals. Biotechnol Prog. 2018;34:828–14. doi:10.1002/btpr.2640.
   PubMed Web of Science ®Google Scholar
• Jones M, Palackal N, Wang F, Gaza-Bulseco G, Hurkmans K, Zhao Y, Chitikila C, Clavier S, Liu S, Menesale E, et al. “High-risk” host cell proteins (HCPs): a multi-company collaborative view. Biotechnol Bioeng. 2021;118:2870–85. doi:10.1002/bit.27808.
   PubMed Web of Science ®Google Scholar
• Fischer SK, Cheu M, Peng K, Lowe J, Araujo J, Murray E, McClintock D, Matthews J, Siguenza P, Song A, et al. Specific immune response to phospholipase B-like 2 protein, a host cell impurity in lebrikizumab clinical material. AAPS J. 2017;19:254–63. doi:10.1208/s12248-016-9998-7.
   PubMed Web of Science ®Google Scholar
• Graf T, Tomlinson A, Yuk IH, Kufer R, Spensberger B, Falkenstein R, Shen A, Li H, Duan D, Liu W, et al. Identification and characterization of polysorbate-degrading enzymes in a monoclonal antibody formulation. J Pharm Sci. 2021;110:3558–67. doi:10.1016/j.xphs.2021.06.033.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015;70:748–56. doi:10.1136/thoraxjnl-2014-206719.
   PubMed Web of Science ®Google Scholar
• Gao SX, Zhang Y, Stansberry-Perkins K, Buko A, Bai S, Nguyen V, Brader ML. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. Biotechnol Bioeng. 2011;108:977–82. doi:10.1002/bit.22982.
   PubMed Web of Science ®Google Scholar
• Dixit N, Salamat-Miller N, Salinas PA, Taylor KD, Basu SK. Residual host cell protein promotes polysorbate 20 degradation in a sulfatase drug product leading to free fatty acid particles. J Pharm Sci. 2016;105:1657–66. doi:10.1016/j.xphs.2016.02.029.
   PubMed Web of Science ®Google Scholar
• Robert F, Bierau H, Rossi M, Agugiaro D, Soranzo T, Broly H, Mitchell-Logean C. Degradation of an Fc-fusion recombinant protein by host cell proteases: identification of a CHO cathepsin D protease. Biotechnol Bioeng. 2009;104:1132–41. doi:10.1002/bit.22494.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, US Department of Health and Human Services. Test procedures and acceptance criteria for biotechnological/biological products. Rockville (MD): Food and Drug Administration, US Department of Health and Human Services; 1999.
   Google Scholar
• Vanderlaan M, Sandoval W, Liu P. Hamster phospholipase B-like 2 (PLBL2), a host cell protein impurity in CHO-derived therapeutic monoclonal antibodies. BioProcess Int. 2015;13:18–29.
   Google Scholar
• Chiu J, Valente KN, Levy NE, Min L, Lenhoff AM, Lee KH. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations. Biotechnol Bioeng. 2017;114:1006–15. doi:10.1002/bit.26237.
   PubMed Web of Science ®Google Scholar
• Hall T, Sandefur SL, Frye CC, Tuley TL, Huang L. Polysorbates 20 and 80 degradation by group XV lysosomal phospholipase A2 isomer X1 in monoclonal antibody formulations. J Pharm Sci. 2016;105:1633–42. doi:10.1016/j.xphs.2016.02.022.
   PubMed Web of Science ®Google Scholar
• Dwivedi M, Blech M, Presser I, Garidel P. Polysorbate degradation in biotherapeutic formulations: identification and discussion of current root causes. Int J Pharm. 2018;552:422–36. doi:10.1016/j.ijpharm.2018.10.008.
   PubMed Web of Science ®Google Scholar
• Zhu-Shimoni J, Yu C, Nishihara J, Wong RM, Gunawan F, Lin M, Krawitz D, Liu P, Sandoval W, Vanderlaan M, et al. Host cell protein testing by ELISAs and the use of orthogonal methods. Biotechnol Bioeng. 2014;111:2367–79. doi:10.1002/bit.25327.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xiao H, Goren M, Burakov D, Chen G, Li N, Tustian A, Adams B, Mattila J, Bak H, et al. Putative phospholipase B-like 2 is not responsible for polysorbate degradation in monoclonal antibody drug products. J Pharm Sci. 2020;109:2710–18. doi:10.1016/j.xphs.2020.05.028.
   PubMed Web of Science ®Google Scholar
• Cao S, Martinez-Martin N. Unbiased identification of extracellular protein–protein interactions for drug target and biologic drug discovery. IntechOpen; 2021.
   Google Scholar
• Zhang S, Xiao H, Molden R, Qiu H, Li N. Rapid polysorbate 80 degradation by liver carboxylesterase in a monoclonal antibody formulated drug substance at early stage development. J Pharm Sci. 2020;109:3300–07. doi:10.1016/j.xphs.2020.07.018.
   PubMed Web of Science ®Google Scholar
• Zhou M, Li Q, Wang R. Current experimental methods for characterizing protein-protein interactions. Chem Med Chem. 2016;11:738–56. doi:10.1002/cmdc.201500495.
   Google Scholar
• Nivedha S, Babu PR, Senthilnathan K. Surface plasmon resonance physics and technology. Curr Sci. 2018;115:56–63. doi:10.18520/cs/v115/i1/56-63.
   Web of Science ®Google Scholar
• Jerabek-Willemsen M, André T, Wanner R, Roth HM, Duhr S, Baaske P, Breitsprecher D. MicroScale thermophoresis: interaction analysis and beyond. J Mol Struct. 2014;1077:101–13. doi:10.1016/j.molstruc.2014.03.009.
   Web of Science ®Google Scholar
• Kairys V, Baranauskiene L, Kazlauskiene M, Matulis D, Kazlauskas E. Binding affinity in drug design: experimental and computational techniques. Expert Opin Drug Discov. 2019;14:755–68. doi:10.1080/17460441.2019.1623202.
   PubMed Web of Science ®Google Scholar
• Khodabandehloo A, Chen DDY. Particle sizing methods for the detection of protein aggregates in biopharmaceuticals. Bioanalysis. 2017;9:313–26. doi:10.4155/bio-2016-0269.
   PubMed Web of Science ®Google Scholar
• Wang W, Roberts CJ. Protein aggregation – mechanisms, detection, and control. Int J Pharm. 2018;550:251–68. doi:10.1016/j.ijpharm.2018.08.043.
   PubMed Web of Science ®Google Scholar
• Hambly D, Gross M. Laser flash photochemical oxidation to locate heme binding and conformational changes in myroglobin. Int J Mass spectrom. 2007;259:124–29. doi:10.1016/j.ijms.2006.08.018.
   Web of Science ®Google Scholar
• Li X, Wang F, Li H, Richardson DD, Roush DJ. The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation. Antibody Therap. 2022;5:42–54. doi:10.1093/abt/tbac002.
   PubMedGoogle Scholar
• Chen I-H, Xiao H, Li N. Methods for characterizing low-abundance host cell proteins. USPTO US20210302433A1. 2021.
   Google Scholar
• Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, Reitz RE, Krauss RM. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem. 2008;54:1307–16. doi:10.1373/clinchem.2007.100586.
   PubMed Web of Science ®Google Scholar
• Costa AR, Rodrigues ME, Henriques M, Oliveira R, Azeredo J. Glycosylation: impact, control and improvement during therapeutic protein production. Crit Rev Biotechnol. 2014;34:281–99. doi:10.3109/07388551.2013.793649.
   PubMed Web of Science ®Google Scholar
• Leney AC, Heck AJR. Native mass spectrometry: what is in the name? J Am Soc Mass Spectrom. 2017;28:5–13. doi:10.1007/s13361-016-1545-3.
   Web of Science ®Google Scholar
• Bunc M, Hadži S, Graf C, Bončina M, Lah J. Aggregation time machine: a platform for the prediction and optimization of long-term antibody stability using short-term kinetic analysis. J Med Chem. 2022;65:2623–32. doi:10.1021/acs.jmedchem.1c02010.
   PubMed Web of Science ®Google Scholar
• Jones LM, Sperry JB, Carroll JA, Gross ML. Fast photochemical oxidation of proteins for epitope mapping. Anal Chem. 2011;83:7657–61. doi:10.1021/ac2007366.
   PubMed Web of Science ®Google Scholar
• Sun Y, Izadi S, Callahan M, Deperalta G, Wecksler AT. Antibody-receptor interactions mediate antibody-dependent cellular cytotoxicity. J Biol Chem. 2021;297:100826. doi:10.1016/j.jbc.2021.100826.
   PubMed Web of Science ®Google Scholar
• Schick AJ, Lundin V, Low J, Peng K, Vandlen R, Wecksler AT. Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody. mAbs. 2022;14:2028337. doi:10.1080/19420862.2022.2028337.
   PubMed Web of Science ®Google Scholar
• Li KS, Shi LQ, Gross ML. Mass spectrometry-based Fast Photochemical Oxidation of Proteins (FPOP) for higher order structure characterization. Acc Chem Res. 2018;51:736–44. doi:10.1021/acs.accounts.7b00593.
   PubMed Web of Science ®Google Scholar
• Rogniaux H, Van Dorsselaer A, Barth P, Biellmann JF, Barbanton J, van Zandt M, Chevrier B, Howard E, Mitschler A, Potier N, et al. Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies. J Am Soc Mass Spectrom. 1999;10:635–47. doi:10.1016/S1044-0305(99)00030-6.
   PubMed Web of Science ®Google Scholar
• Ren C, Bailey AO, VanderPorten E, Oh A, Phung W, Mulvihill MM, Harris SF, Liu Y, Han G, Sandoval W, et al. Quantitative determination of protein–ligand affinity by size exclusion chromatography directly coupled to high-resolution native mass spectrometry. Anal Chem. 2019;91:903–11. doi:10.1021/acs.analchem.8b03829.
   PubMed Web of Science ®Google Scholar
• Hunter AK, Wang X, Suda EJ, Herberg JT, Shell RE, Thomas KE, Dufield RL, Gustafson ME, Mozier NM, Ho SV, et al. Separation of product associating E. coli host cell proteins OppA and DppA from recombinant apolipoprotein A-I Milano in an industrial HIC unit operation. Biotechnol Prog. 2009;25:446–53. doi:10.1002/btpr.106.
   PubMed Web of Science ®Google Scholar
• Doneanu CE, Xenopoulos A, Fadgen K, Murphy J, Skilton SJ, Prentice H, Stapels M, Chen W. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry. mAbs. 2012;4:24–44. doi:10.4161/mabs.4.1.18748.
   Google Scholar
• Liu X, Chen Y, Zhao Y, Liu-Compton V, Chen W, Payne G, Lazar AC. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. J Pharm Biomed Anal. 2019;174:500–08. doi:10.1016/j.jpba.2019.06.021.
   PubMed Web of Science ®Google Scholar
• Valente KN, Lenhoff AM, Lee KH. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing. Biotechnol Bioeng. 2015;112:1232–42. doi:10.1002/bit.25515.
   PubMed Web of Science ®Google Scholar
• Baycin-Hizal D, Tabb DL, Chaerkady R, Chen L, Lewis NE, Nagarajan H, Sarkaria V, Kumar A, Wolozny D, Colao J, et al. Proteomic analysis of Chinese hamster ovary cells. J Proteome Res. 2012;11:5265–76. doi:10.1021/pr300476w.
   PubMedGoogle Scholar
• Wilson MR, Easterbrook-Smith SB. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. Biochim Biophys Acta. 1992;1159:319–26. doi:10.1016/0167-4838(92)90062-I.
   PubMedGoogle Scholar
• Lakomek K, Dickmanns A, Kettwig M, Urlaub H, Ficner R, Lübke T. Initial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallography. BMC Struct Biol. 2009;9:1–17. doi:10.1186/1472-6807-9-56.
   PubMed Web of Science ®Google Scholar
• Glukhova A, Hinkovska-Galcheva V, Kelly R, Abe A, Shayman J, Tesmer J. Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase. Nat Commun. 2014;6:1–12.
   Web of Science ®Google Scholar
• Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-.ANG. resolution. Biochemistry. 1981;20:2361–70. doi:10.1021/bi00512a001.
   PubMed Web of Science ®Google Scholar
• Tran B, Grosskopf V, Wang X, Yang J, Walker D, Yu C, McDonald P. Investigating interactions between phospholipase B-Like 2 and antibodies during Protein A chromatography. J Chrom A. 2016;1438:31–38. doi:10.1016/j.chroma.2016.01.047.
   PubMed Web of Science ®Google Scholar
• Bosteels H, Chen S, Farrow K, Kucia-Tran R, Lewis WJK, Thomson AS. Antibodies with reduced binding to process impurities. USPTO WO2018065389. 2017.
   Google Scholar
• Wilson MR, Roeth PJ, Easterbrook-Smith SB. Clusterin enhances the formation of insoluble immune complexes. Biochem Biophys Res Commun. 1991;177:985–90. doi:10.1016/0006-291X(91)90635-K.
   PubMed Web of Science ®Google Scholar
• Dumet C, Pottier J, Gouilleux-Gruart V, Watier H. Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development. mAbs. 2019;11:1341–50. doi:10.1080/19420862.2019.1664365.
   PubMed Web of Science ®Google Scholar
• Gunawan F, Hsiao Y-C, Krawitz DC, Lin MS, Vanderlaan M, Yuk RVH. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products. USPTO WO2015038884A2. 2016.
   Google Scholar
• Singh SK, Mishra A, Yadav D, Budholiya N, Rathore AS. Understanding the mechanism of copurification of “difficult to remove” host cell proteins in rituximab biosimilar products. Biotechnol Prog. 2020;36:e2936.
   PubMed Web of Science ®Google Scholar
• Pacis E, Yu M, Autsen J, Bayer R, Li F. Effects of cell culture conditions on antibody N-linked glycosylation—what affects high mannose 5 glycoform. Biotechnol Bioeng. 2011;108:2348–58. doi:10.1002/bit.23200.
   PubMed Web of Science ®Google Scholar
• Rameez S, Gowtham YK, Nayar G, Mostafa SS. Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar. Biotechnol Prog. 2021;37:e3176. doi:10.1002/btpr.3176.
   PubMed Web of Science ®Google Scholar
• Bhargava AC, Mains K, Siu A, Gu J, Zarzar J, Yi L, Yuk IH. High-throughput, fluorescence-based esterase activity assay for assessing polysorbate degradation risk during biopharmaceutical development. Pharm Res. 2021;38:397–413. doi:10.1007/s11095-021-03011-1.
   PubMed Web of Science ®Google Scholar
• Garcia NK, Sreedhara A, Deperalta G, Wecksler AT. Optimizing hydroxyl radical footprinting analysis of biotherapeutics using internal standard dosimetry. J Am Soc Mass Spectrom. 2020;31:1563–71. doi:10.1021/jasms.0c00146.
   PubMed Web of Science ®Google Scholar
• Kirshenbaum N, Michaelevski I, Sharon M. Analyzing large protein complexes by structural mass spectrometry. J Vis Exp. 2010;1954:e1954.
   Google Scholar
• van de Waterbeemd M, Fort KL, Boll D, Reinhardt-Szyba M, Routh A, Makarov A, Heck AJR. High-fidelity mass analysis unveils heterogeneity in intact ribosomal particles. Nat Methods. 2017;14:283–86. doi:10.1038/nmeth.4147.
   PubMed Web of Science ®Google Scholar
• Marty MT, Baldwin AJ, Marklund EG, Hochberg GKA, Benesch JLP, Robinson CV. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal Chem. 2015;87:4370–76. doi:10.1021/acs.analchem.5b00140.
   PubMed Web of Science ®Google Scholar
• An H, Landis JT, Bailey AG, Marron JS, Dittmer DP. dr4pl: a stable convergence algorithm for the 4 parameter logistic model. R Journal. 2019;11:171. doi:10.32614/RJ-2019-003.
   Web of Science ®Google Scholar
• Ooi J, Traini D, Young PM. Graphing software for medical writers. Medical Writing. 2014;23:41–44. doi:10.1179/2047480613Z.000000000185.
   Google Scholar